PGC1α plays a pivotal role in renal fibrosis via regulation of fatty acid metabolism in renal tissue.
10.11817/j.issn.1672-7347.2022.200953
- Author:
Rui ZHANG
1
;
Jia ZENG
2
;
Zhijun DENG
2
;
Guangming YIN
2
;
Long WANG
2
;
Jing TAN
3
Author Information
1. Department of Urology, Third Xiangya Hospital, Central South University, Changsha 410013, China. 1055523577@qq.com.
2. Department of Urology, Third Xiangya Hospital, Central South University, Changsha 410013, China.
3. Department of Urology, Third Xiangya Hospital, Central South University, Changsha 410013, China. 4485366@qq.com.
- Publication Type:Journal Article
- Keywords:
fatty acid metabolism;
peroxisome proliferator-actinated receptor gamma coactivator 1α;
renal fibrosis
- MeSH:
Animals;
Fatty Acids;
Fibrosis;
Lipid Metabolism;
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha/metabolism*;
Renal Insufficiency, Chronic
- From:
Journal of Central South University(Medical Sciences)
2022;47(6):786-793
- CountryChina
- Language:English
-
Abstract:
Renal fibrosis is a common and irreversible pathological feature of end-stage renal disease caused by multiple etiologies. The role of inflammation in renal fibrosis tissue has been generally accepted. The latest view is that fatty acid metabolism disorder contributes to renal fibrosis. peroxisome proliferator activated receptor-gamma coactivator 1α (PGC1α) plays a key role in fatty acid metabolism, regulating fatty acid uptake and oxidized protein synthesis, preventing the accumulation of lipid in the cytoplasm, and maintaining a dynamic balanced state of intracellular lipid. In multiple animal models of renal fibrosis caused by acute or chronic kidney disease, or even age-related kidney disease, almost all of the kidney specimens show the down-regulation of PGC1α. Upregulation of PGC1α can reduce the degree of renal fibrosis in animal models, and PGC1α knockout animals exhibit severe renal fibrosis. Studies have demonstrated that AMP-activated protein kinase (AMPK), MAPK, Notch, tumor necrosis factor-like weak inducer of apoptosis (TWEAK), epidermal growth factor receptor (EGFR), non-coding RNA (ncRNAs), liver kinase B1 (LKB1), hairy and enhancer of split 1 (Hes1), and other pathways regulate the expression of PGC1α and affect fatty acid metabolism. But some of these pathways interact with each other, and the effect of the integrated pathway on renal fibrosis is not clear.
